Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer - Wikidata - wikimedia - TriplyDB

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer

http://www.wikidata.org/entity/Q35740123

about

c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development.MicroRNA-206 Prevents the Pathogenesis of Hepatocellular Carcinoma Via Modulating Expression of cMet and Cdk6.MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.

P2860

Q33608524-B95B69D3-1EBA-4230-8009-C02CD1B01A10 Q33635350-27ADA85C-9ECB-4E4C-8F03-D7638705A7CA Q33685465-AE0CB900-0879-47CF-ADB3-539F41CBFB7B Q36729381-38D17004-46C3-4034-BF49-1564EDE8F0C9 Q36847230-48FBD230-DC59-43CB-AA6D-D6CDAAD4A63F Q36922232-E6F94260-3507-4A7D-A0D5-7988C5527531 Q37520584-3D5F71A0-F953-4B25-8B45-F27317FA3C20 Q37693388-7315D78A-E734-45AC-9DBE-3947B848DB72 Q37699310-B7868386-53B8-409D-AD39-FEB59FEF22CC Q38823802-4C268862-AC9A-453A-96BA-E62CA278B0C2 Q40132515-80878283-6665-4F0B-A41A-E806ABD63ED7 Q41495543-5B189E20-C4BE-4F19-B70B-D7EA22AF24F1 Q45059708-A216FA55-A87A-42E0-9780-227068335979 Q46763707-1508B1E5-1818-4A1D-801A-E881DB0221F2 Q55176168-83A6A284-D4B3-4E44-AFE4-F7B275C47212

P2860

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer

http://www.wikidata.org/entity/Q35740123

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@ast

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@en

type

label

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@ast

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@en

prefLabel

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@ast

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@en

P1433

Q35740123-83923C74-9B08-41C3-AB30-BC88C0D1BFA7

P1476

Q35740123-AB69F445-7D1B-4997-AB4B-7532A0ECFF22

P2093

Q35740123-03690B87-CFC2-4E9D-8421-9EBA6F1C1E6D

Q35740123-37760D50-B4C6-4F36-89A6-EE2D9DD9C58E

Q35740123-447E8C0C-4A97-4F5F-A2D8-21D6E23DCD0C

Q35740123-55922F61-7D6C-429B-AC0C-A480F1FCD414

Q35740123-7BC9C448-C768-4770-9CC1-3C84EA757CD9

Q35740123-83175311-3C53-4B71-8048-26EDF12631D4

Q35740123-83E0412A-5C70-4F76-A806-3778C3D2ACC4

Q35740123-CD8A971C-F3C9-427A-BAE1-D247AEE6E524

Q35740123-D7D8C54C-0479-4607-89CD-B1DFD23C5272

Q35740123-D7EC729B-41F9-4E65-AF87-5E47B6F2DFE7

P2860

Q35740123-08719425-805A-462C-A924-22ED88164A90

Q35740123-14BEFE7A-679A-498C-AAE0-AA691A2567E9

Q35740123-16BFE0F4-9FB1-418D-B492-E051B3DE247C

Q35740123-211A93C2-0E4B-46B5-821D-2590C39119FC

Q35740123-26BCA86D-0E06-4B77-A9DA-4107FA57CAA5

Q35740123-3542B026-5A12-48A3-B798-845D00A947DF

Q35740123-39D98139-4054-47A9-AE6D-EB952F902A26

Q35740123-3CC939F7-FEDA-4D25-9E4C-6A04E3B0259F

Q35740123-4338619B-F274-405E-9D44-C9F28E3AAFD7

Q35740123-454C54B6-C705-4CE3-9D40-470174C172EB

P304

Q35740123-62BF3519-0587-49DD-9361-0189FC4F9257

P31

Q35740123-45A02BE6-A4B9-4664-926F-045E49F500A8

P356

Q35740123-16A406A8-8AB5-487B-961B-4906988639A3

P407

Q35740123-9532114B-27F0-4124-BC63-EF09CE29857A

P433

Q35740123-24652C2F-B7EB-484B-A325-6558F1045007

P478

Q35740123-8FDB56BA-BC70-4FF9-B3A8-AF84D369966E

P577

Q35740123-3DE6B9AE-D1B5-472F-B537-8ED84697E87F

P5875

Q35740123-257B522C-CDC9-4144-9287-FF4001ABC71F

P698

Q35740123-5E806BF3-12A3-4BB9-B5A1-488616B75377

P921

Q35740123-AAC3E779-4229-488C-903A-31858BCDA10A

P932

Q35740123-2C2EA720-DEF1-4F8D-80B5-B4677D8EDC96

P356

ONCOTARGET.3166

P1433

P1476

Distinct anti-oncogenic effect ...... t mouse models of liver cancer

@en

P2093

Diego F Calvisi

http://www.w3.org/2001/XMLSchema#string

Guisheng Song

http://www.w3.org/2001/XMLSchema#string

Heng Wu

http://www.w3.org/2001/XMLSchema#string

Junfang Ji

http://www.w3.org/2001/XMLSchema#string

Junyan Tao

http://www.w3.org/2001/XMLSchema#string

Ning Ding

http://www.w3.org/2001/XMLSchema#string

Xiaolei Li

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Xin Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells

MicroRNA expression, survival, and response to interferon in liver cancer

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

Sorafenib in advanced hepatocellular carcinoma

A pancreatic islet-specific microRNA regulates insulin secretion

Epidemiology of viral hepatitis and hepatocellular carcinoma

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells

MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.

P304

6977-6988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3166

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273467082

http://www.w3.org/2001/XMLSchema#string

P698

25762642

http://www.w3.org/2001/XMLSchema#string

P921

P932

4466663

http://www.w3.org/2001/XMLSchema#string